Osteoporosis drug showdown: alendronate vs teriparatide in new Follow-Up trial
Disease control
ENROLLING_BY_INVITATION
This study looks at 40 adults with osteoporosis who already completed a year of treatment with either Alendronate or Teriparatide. In this follow-up, participants will switch to the other drug for another year to see which works better for bone loss. The goal is to find a more pe…
Phase: PHASE4 • Sponsor: Paul F Netzel • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC